User profiles for Homie Razavi
 | Homie RazaviCenter for Disease Analysis Foundation Verified email at cdafound.org Cited by 73278 |
[HTML][HTML] Global epidemiology and genotype distribution of the hepatitis C virus infection
The treatment of chronic hepatitis C virus (HCV) infection has the potential to change
significantly over the next few years as therapeutic regimens are rapidly evolving. However, the …
significantly over the next few years as therapeutic regimens are rapidly evolving. However, the …
[PDF][PDF] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH)
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. …
(NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. …
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Background At global level, there are 37 million people infected with HIV and 115 million
people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV–HCV …
people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV–HCV …
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors
Importance Understanding the major health problems in the United States and how they are
changing over time is critical for informing national health policy. Objectives To measure the …
changing over time is critical for informing national health policy. Objectives To measure the …
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Background: The hepatitis C pandemic has been systematically studied and characterized
in North America and Europe, but this important public health problem has not received …
in North America and Europe, but this important public health problem has not received …
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country‐specific …
epidemiological data. A comprehensive review of the literature was used to gather country‐specific …
[PDF][PDF] Chronic hepatitis C virus (HCV) disease burden and cost in the United States
Hepatitis C virus (HCV) infection is a leading cause of cirrhosis, hepatocellular carcinoma,
and liver transplantation. A better understanding of HCV disease progression and the …
and liver transplantation. A better understanding of HCV disease progression and the …
Hepatitis C virus infection
Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …
